H.R. 401 (119th)Bill Overview

No Taxpayer Funding for the World Health Organization Act

International Affairs|International Affairs
Sponsor
Cosponsors
Support
Republican
Introduced
Jan 14, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Foreign Affairs.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

This bill prohibits the United States from providing any assessed or voluntary contributions to the World Health Organization (WHO), effective on the date of enactment. It contains a single operative provision and does not include exceptions, offsets, or implementation details.

Why people may split

Progressives emphasize global health risks; conservatives emphasize sovereignty and accountability.

Watch point

Relative to its intended legislative type, this bill is a concise, narrowly targeted statutory prohibition that is clear in its primary operative command but limited in supporting detail.

This bill prohibits the United States from providing any assessed or voluntary contributions to the World Health Organization (WHO), effective on the date of enactment.

It contains a single operative provision and does not include exceptions, offsets, or implementation details.

The statute would bar both mandatory assessed payments and discretionary voluntary funding to the WHO.

Passage30/100

Narrow and administratively simple but highly controversial; lacks compromise features and faces significant Senate and executive branch obstacles.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a concise, narrowly targeted statutory prohibition that is clear in its primary operative command but limited in supporting detail.

Contention80/100

Progressives emphasize global health risks; conservatives emphasize sovereignty and accountability.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesReduces federal expenditures that otherwise would fund the WHO.
  • Potential benefitAllows Congress and the Administration to reallocate funds to domestic health priorities.
  • Potential benefitExerts financial pressure that supporters expect could prompt WHO governance reforms.
Likely burdened
  • Potential burdenReduces U.S. influence and voting leverage within the WHO governance process.
  • Potential burdenMay weaken global disease surveillance, preparedness, and pandemic response coordination.
  • Potential burdenCould disrupt WHO-funded vaccination, outbreak, and technical assistance programs abroad.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize global health risks; conservatives emphasize sovereignty and accountability.
Progressive5%

Likely strongly opposed.

They would view the bill as a unilateral cut to global health cooperation that undermines pandemic preparedness and vaccine programs.

They would emphasize impacts on low-income countries and U.S. global leadership in health.

Likely resistant
Centrist30%

Overall skeptical or opposed but open to compromise.

They would weigh sovereignty and oversight concerns against public health and diplomatic consequences.

They would look for measured reforms, narrow exceptions, or phased approaches rather than an absolute ban.

Likely resistant
Conservative90%

Likely broadly supportive.

They would view the bill as protecting taxpayer dollars, limiting support for an international body they see as needing accountability, and reasserting U.S. control over funding decisions.

They may argue the WHO mismanaged past crises and needs reform or pressure.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

Narrow and administratively simple but highly controversial; lacks compromise features and faces significant Senate and executive branch obstacles.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No Congressional Budget Office cost estimate included
  • Potential conflicts with treaty or international commitments unclear
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize global health risks; conservatives emphasize sovereignty and accountability.

Narrow and administratively simple but highly controversial; lacks compromise features and faces significant Senate and executive branch ob…

Unlocked analysis

Relative to its intended legislative type, this bill is a concise, narrowly targeted statutory prohibition that is clear in its primary operative command but limited in supporting detail.

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis